We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves Novartis Kisqali for Combination Breast Cancer Therapy

News   Mar 21, 2017 | Original story from Novartis

 
FDA Approves Novartis Kisqali for Combination Breast Cancer Therapy
 
 
 

RELATED ARTICLES

Fungus Chemistry May Mimic Opioids With Fewer Side Effects

News

The hunt for an opioid alternative has made a leap forward – a unique fungus may be able to mimic opioid suggesting it could be a safer less addictive drug, helping address the opioid epidemic of deaths by overdose.

READ MORE

Post-surgery Surveillance – Less May Be More for Low-risk Thyroid Cancer Patients

News

A study has found that some patients, known as maximizers, consume a high level of medical resources without clear evidence of better outcomes.

READ MORE

Giving the Immune System a Helping Hand To Find Hidden Cancer Cells

News

Researchers have developed a new system that helps the immune system spot and eliminate cancer cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE